Filtros de búsqueda

Lista de obras de Michela Del Prete

5-Fluorouracil pharmacogenomics: still rocking after all these years?

scientific article published on February 2011

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.

artículo científico publicado en 2016

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.

artículo científico publicado en 2016

Angiogenetic pathway as a therapeutic target in renal cell carcinoma

artículo científico publicado el 1 de febrero de 2012

Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients

artículo científico publicado en 2014

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients

artículo científico publicado en 2013

Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.

artículo científico publicado en 2013

Clinical evidence for three distinct gastric cancer subtypes: time for a new approach

artículo científico publicado en 2013

Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas

artículo científico publicado en 2014

Hepatic arterial embolization in patients with neuroendocrine tumors

artículo científico publicado en 2014

Insulin resistance and acne: a new risk factor for men?

artículo científico publicado en 2012

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

artículo científico publicado en 2016

Limitations of Chromogranin A in clinical practice

artículo científico publicado en 2012

Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.

artículo científico publicado en 2016

Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation

artículo científico publicado en 2013

Multiple ovarian cysts in a young girl with severe hypothyroidism

artículo científico publicado en 2007

Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.

artículo científico publicado en 2010

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

scientific article published on 05 April 2017

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study.

artículo científico publicado en 2017

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

artículo científico publicado en 2012

Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication

artículo científico publicado en 2014

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

artículo científico publicado en 2015

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management

artículo científico publicado en 2015

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

artículo científico publicado en 2015

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

artículo científico publicado en 2015

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients

artículo científico publicado en 2012

Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab

artículo científico publicado en 2013

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

artículo científico publicado en 2014

State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors

artículo científico publicado el 1 de febrero de 2011

Stricter criteria increase the validity of a quick intraoperative parathyroid hormone assay in primary hyperparathyroidism.

artículo científico publicado en 2009

The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

scientific article published on 04 August 2016

The Tower of Babel of liver metastases from colorectal cancer: are we ready for one language?

artículo científico

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.

artículo científico publicado en 2016

The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management

artículo científico publicado en 2012

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis.

artículo científico publicado en 2015

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

scientific article published on 03 January 2014

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients

artículo científico publicado en 2013